To provide more flexible treatment options for opioid use disorder among the incarcerated, San Mateo County Health’s Correctional Health Services has adopted Brixadi, a long-acting injectable buprenorphine, as part of its Medication Assisted Treatment program for at risk individuals in San Mateo County’s correctional facilities, according to the county.
Buprenorphine reduces cravings and withdrawal symptoms. Unlike daily tablets or strips, Brixadi provides steady relief in weekly or monthly doses. This flexibility gives health care providers more options to meet each patient’s needs and offers stability even in the unpredictable environment of correctional facilities, where release dates and transfers often come with little notice, according to the county.
(0) comments
Welcome to the discussion.
Log In
Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.